European Archives - Page 656 of 1002 - European Medical Journal

Quality of Life and Psychosocial Issue in Skin Disease

Awareness of the impact that skin diseases can have on a patients’ quality of life has improved markedly within the dermatology community in recent…

First-of-its-Kind Topical Spray Proving Effective at Treating Atopic Dermatitis

Cyclatop, a 5% cyclosporine topical spray, may be poised to deliver a significant therapeutic improvement for atopic dermatitis patients. A new study by…

Beauticians Beware: (Meth)acrylate May Cause Contact Allergy

(Meth)acrylates are important components of acrylic nails, gel nails, and gel polish nails and could be the cause of an allergic epidemic, warns a…

EMJ Oncology 6 [Suppl 1] 2018

Dr Oaknin welcomed the delegates to the symposium and presented the objectives and agenda for the meeting as well as a case study presentation. Dr Birrer…

The Role of PARP Inhibitors in Ovarian Cancer: An Emerging Picture

Dr Birrer presented on the current landscape of platinum-sensitive recurrent ovarian cancer (PSR OC), including USA and European treatment guidelines.

FutureNova wins prestigious Plastics Industry Award

Chelmsford based FutureNova is celebrating having won Consumer product Design of the Year at the prestigious Plastics Industry Award for its innovative…

Positive Impact of Patient Prehabilitation for Surgery

A study has shown that prehabilitation, a structured exercise and nutrition conditioning programme prior to operation, leads to an improvement in…

Laparoscopic Pancreatoduodenectomy Shortens Hospital Stay Compared with Open Pancreatoduodenectomy

Laparoscopic pancreatoduodenectomy (LPD) has been shown by the results of the PADULAP trial, which was conducted from 2013–2017, to lead to both shorter…

This September 2018, EMJ Supports…

This September, EMJ proudly showcases its support for World Alzheimer’s Month and National Doodle Day.

Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Looking for the Right Patient and the Right Time

Transjugular intrahepatic portosystemic shunt. Portal hypertension is the main complication of cirrhosis and occurs due to increased pressure within the…